As the microbiome therapeutic landscape shifts from laboratory discovery to clinical reality, Creative Biolabs has announced the expansion of its integrated Chemistry, Manufacturing, and Controls (CMC) services.
SHIRLEY, NY, April 08, 2026 /24-7PressRelease/ — By synchronizing specialized LBP formulation development with rigorous quality establishment, the organization aims to overcome the “viability barrier” that currently hinders many next-generation probiotics (NGPs) and live biotherapeutic products (LBPs).
Bridging the Gap Between Strain Discovery and Clinical Success
The transition of a microbial strain into a stabilized pharmaceutical dosage form remains one of the most technical hurdles in biotechnology. Unlike traditional biologics, LBPs involve living organisms that are highly sensitive to oxygen, gastric acidity, and moisture. Creative Biolabs’ enhanced framework utilizes a Quality by Design (QbD) approach to ensure that therapeutic candidates maintain a potency of _109 colony forming units (CFUs) throughout their shelf life.
“The industry is moving beyond simple microbial counts. Today, regulatory success depends on functional characterization,” says a senior scientist at Creative Biolabs. “Our mission is to treat the microbial strain as a complex pharmaceutical entity, ensuring it survives the harsh gastrointestinal transit to deliver its intended therapeutic effect.”
Integrated Analytical and Formulation Excellence
To de-risk the Investigational New Drug (IND) filing process, Creative Biolabs offers an end-to-end solution focusing on:
Pre-formulation Characterization: Assessing strain sensitivity to environmental stressors and optimizing lyophilization (freeze-drying) cycles.
Advanced Delivery Systems: Developing enteric-coated capsules and pH-sensitive oral suspensions to bypass gastric degradation.
Method Validation: Establishing standardized probiotic quality control and release testing protocols that meet global pharmacopoeial standards.
Expert Insight: Redefining Potency and Purity
A critical component of this expansion is the refinement of functional potency assays. Unlike standard microbial testing, which only measures total growth, Creative Biolabs’ specialized assays measure the organism’s actual biological activity—such as metabolite production or immune pathway modulation.
“Standard probiotic QC often overlooks the specific handling requirements of strict anaerobes. Creative Biolabs provides the specialized anaerobic infrastructure and regulatory foresight necessary to navigate the unique CMC challenges of living medicines,” notes a lead microbiologist at the firm.
Technical Deep Dive: Navigating LBP Quality Standards
In alignment with evolving global regulations, Creative Biolabs has integrated high-density information into its service protocols to address common industry technical queries:
Differentiation in Testing: Probiotic Quality Control (QC) requires specialized enumeration techniques to distinguish viable, beneficial microbes from potential contaminants in a high-density matrix.
Stability Assessment: The organization conducts both real-time and accelerated stability studies to determine precise shelf life and storage conditions (2-8°C or room temperature).
Bioburden & Safety: Rigorous monitoring for microbial contaminants and antibiotic susceptibility resistance (AST) ensures that engineered strains do not pose risks of horizontal gene transfer.
About Creative Biolabs
Creative Biolabs specializes in microbiome research, antifungal drug discovery, and synthetic biology. With ISO 9001:2015-certified facilities and a team of multi-disciplinary experts, the company provides phase-appropriate strategies to accelerate the development of living medicines from early-stage research to IND-enabling CMC data generation.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer:
The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
